tiprankstipranks
Trending News
More News >
Capricor Therapeutics (GB:0HTB)
LSE:0HTB
UK Market

Capricor Therapeutics (0HTB) Income Statement

Compare
0 Followers

Capricor Therapeutics Income Statement

Last quarter (Q1 2025), Capricor Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q1, Capricor Therapeutics's net income was $-24.39B. See Capricor Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 22.27M$ 25.18M$ 2.55M$ 244.90K$ 310.25K
Gross Profit
$ 20.85M$ 24.11M$ 1.85M$ -799.00$ -8.15M
Operating Expenses
$ 63.41M$ 48.19M$ 32.25M$ 21.18M$ 14.00M
Depreciation and Amortization
$ 1.40M$ 1.07M$ 694.87K$ 245.70K$ 143.89K
EBITDA
$ -41.17M$ -23.01M$ -29.16M$ -20.69M$ -13.55M
Operating Income
$ -42.56M$ -24.08M$ -29.70M$ -20.94M$ -13.69M
Other Income/Expenses
$ 2.10M$ 1.79M$ 677.85K$ 915.92K$ 32.94K
Pretax Income
$ -40.47M$ -22.29M$ -29.02M$ -20.02M$ -13.66M
Net Income
$ -40.47M$ -22.29M-$ -19.41M$ -13.48M
Per Share Metrics
Basic EPS
$ -1.15$ -0.83$ -1.18$ -0.84$ -0.87
Diluted EPS
$ -1.15$ -0.83$ -1.18$ -0.84$ -0.87
Weighted Average Shares Outstanding
35.22M 26.78M 24.55M 23.09M 15.57M
Weighted Average Shares Outstanding (Diluted)
35.22M 26.78M 24.55M 23.09M 15.57M
Currency in USD

Capricor Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis